!
Prioritizing IRB submissions during COVID-19 Learn more >
Navigate to the links on the right side of this page to see details about specific submission types.
Send all IRB submissions via email to IRBinbox@fredhutch.org.
For all inquiries or questions, please use our other inbox, IRO@fredhutch.org.
Please take careful note of the following requirements. Failure to follow these requirements may result in delays in IRB review:
Document types: All attachments should be in PDF format. In addition:
OnCore/CTMS Data Entry: All new research involving human subjects must be entered into the OnCore Clinical Trials Management System before submitting to the IRO.
Scientific Review Committee (SRC): If your new study or modification requires SRC review, proof of SRC approval must be included with the submission. The IRO cannot accept the submission until SRC approval is included. For questions about SRC, email CRSSupportedCommittees@fredhutch.org or see https://www.cancerconsortium.org/en/support/study-management/study-start-up/committee-reviews/src.html.
University of Washington Zipline authorization: For investigators whose primary appointments are at UW, documentation of UW Zipline authorization to rely on the Fred Hutch IRB must be included. For more information, see: https://www.washington.edu/research/hsd/is-the-uw-irb-the-right-irb/how-to-ask-for-a-non-uw-irb/
Seattle Children's authorization: For research where Seattle Children's (SCH) is engaged, an “Acknowledgement of Reliance on an External IRB” letter from SCH must be included as part of your submission to the Fred Hutch IRB. For instructions on how to obtain this letter, please review Section A of the SCH-FH Guidance for Relying.
The IRO will return approved stamped documents once approved, or once the PI has satisfied any conditions on approval.
Approved documents will be sent via email to the PI and IRO Contact on file. We will send stamped PDF documents with the following grouped together (where the 0’s represent the IR number):